Navamedic ASA (OSL: NAVA)
Norway
· Delayed Price · Currency is NOK
25.90
+0.50 (1.97%)
Dec 27, 2024, 4:25 PM CET
Navamedic ASA Revenue
Navamedic ASA had revenue of 123.06M NOK in the quarter ending September 30, 2024, a decrease of -12.72%. This brings the company's revenue in the last twelve months to 525.55M, up 4.56% year-over-year. In the year 2023, Navamedic ASA had annual revenue of 512.00M with 33.98% growth.
Revenue (ttm)
525.55M
Revenue Growth
+4.56%
P/S Ratio
n/a
Revenue / Employee
11.68M
Employees
45
Market Cap
457.47M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 512.00M | 129.86M | 33.98% |
Dec 31, 2022 | 382.14M | 103.70M | 37.24% |
Dec 31, 2021 | 278.44M | 68.56M | 32.67% |
Dec 31, 2020 | 209.88M | 21.12M | 11.19% |
Dec 31, 2019 | 188.76M | 4.84M | 2.63% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Nordhealth AS | 513.12M |
Medistim ASA | 541.82M |
Photocure ASA | 526.25M |
Vistin Pharma ASA | 426.52M |
Nykode Therapeutics AS | 46.02M |
Hofseth BioCare ASA | 248.08M |
ArcticZymes Technologies ASA | 110.76M |
Omda AS | 419.59M |